Statements from the Taormina expert meeting on occult hepatitis B virus infection.

By G. Raimondo, J. Allain, M. Brunetto, M. Buendia, Ding‐Shinn Chen, M. Colombo, A. Craxì, F. Donato, C. Ferrari, G. Gaeta and 18 more. Journal of Hepatology, 2008

848 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/90a3037d0abd198675835a5a0d458c8d45c1e008

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. G. Dusheiko
2. X. Forns
3. J. Pawlotsky

In Hepatology

1. D. Moradpour
2. G. Dusheiko
3. X. Forns
4. J. Pawlotsky

Citations in the corpus

• EASL Clinical Practice Guidelines: management of chronic hepatitis B. (2009, background): “The clinical relevance of occult HBV infection (detectable HBV DNA in the liver with low-level [<200 international units (IU)/ml] HBV DNA in blood) is unclear [16].”
• EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. (2012, background): “The clinical relevance of occult HBV infection [detectable HBV DNA in the liver with low level (<200 IU/ml) or undetectable HBV DNA in blood] is unclear [26].”